| |
| |
|
| Insider
Information: |
Khattar Jack A. |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,378,841 |
|
|
Indirect Shares
|
2,118,700 |
|
|
| Direct
Value |
$23,786,490 |
|
|
|
Indirect Value
|
$26,573,476 |
|
|
| Total
Shares |
3,497,541 |
|
|
| Total
Value |
$50,359,965 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -42.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Supernus Pharmaceuticals Inc |
SUPN |
President, CEO, Director |
2024-02-28 |
915,217 |
2024-02-28 |
1,022,450 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
President, CEO, Director |
2016-03-29 |
444,124 |
2016-03-29 |
1,096,250 |
Premium* |
|
|
Scpharmaceuticals Inc. |
SCPH |
Director |
2021-12-03 |
5,000 |
2021-12-03 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,575 |
788,016 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,530 |
799,431 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-16 |
4 |
OE |
$34.01 |
$312,307 |
D/D |
9,182 |
790,249 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,895 |
781,454 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-09-14 |
4 |
OE |
$33.75 |
$46,575 |
D/D |
1,380 |
780,074 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-11-15 |
4 |
OE |
$9.56 |
$17,045 |
D/D |
1,783 |
781,857 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-11-21 |
4 |
OE |
$9.56 |
$8,107 |
D/D |
848 |
781,590 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-11-22 |
4 |
OE |
$9.56 |
$9,168 |
D/D |
959 |
782,018 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-11-23 |
4 |
OE |
$9.56 |
$34,569 |
D/D |
3,616 |
785,034 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-11-25 |
4 |
OE |
$9.56 |
$170,111 |
D/D |
17,794 |
800,569 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-12-20 |
4 |
OE |
$9.56 |
$62,408 |
D/D |
6,528 |
795,962 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-12-21 |
4 |
OE |
$9.56 |
$176,592 |
D/D |
18,472 |
826,053 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-01-17 |
4 |
OE |
$9.56 |
$400,755 |
D/D |
41,920 |
816,619 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-01-18 |
4 |
OE |
$9.56 |
$77,245 |
D/D |
8,080 |
799,253 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-01-31 |
4 |
OE |
$9.56 |
$15,487 |
D/D |
1,620 |
795,937 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-02-01 |
4 |
OE |
$9.56 |
$4,761 |
D/D |
498 |
795,459 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-02-02 |
4 |
OE |
$9.56 |
$215,243 |
D/D |
22,515 |
817,674 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-02-03 |
4 |
OE |
$9.56 |
$3,155 |
D/D |
330 |
804,472 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
833,022 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
864,272 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-09-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
884,267 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
892,463 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
932,005 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-02-03 |
4 |
S |
$42.02 |
$8,404 |
D/D |
(200) |
804,272 |
0 |
% |
|
99 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
